Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Programming

Filter by Specific Population

Filter by Topic

Filter by Infection

Filter by Resource Category

Search results

Current filters: Treatment, Women, English

20 search results

1
2

Decreasing the risk of neural tube defects with dolutegravir: From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage
WelTel: 2018, CATIE
Research summary - Webpage
FDA warns that Prezcobix should not be used by HIV-positive pregnant women: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Biktarvy in women with HIV: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Agencies issue caution about use of dolutegravir by pregnant HIV-positive women: 2018, CATIE
Research summary - Webpage
Quebec study is reassuring about the safety of HIV treatment during pregnancy: 2017, CATIE
Research summary - Webpage
Getting to undetectable: Population differences in Canada: From Prevention in Focus - Fall 2017
2017, CATIE
Research summary - Webpage
B.C. study finds women need help sticking to treatment: 2017, CATIE
Research summary - Webpage
Dolutegravir in women: From TreatmentUpdate 218
2016, CATIE
Research summary - Webpage
Stribild in women: From TreatmentUpdate 218
2016, CATIE
Research summary - Webpage

1
2

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.